Anders Ekblom, Global Head Science and Technology Integration, AstraZeneca




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Anders Ekblom, Global Head Science and Technology Integration, AstraZeneca
Released on: November 22, 2013. © PharmaTelevision Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this interview, filmed in Stockholm at NLSD 2013, Fintan Walton discusses with Anders Ekblom, Global Head Science and Technology Integration, how AstraZeneca are bringing external innovation into the organisation through pre-competitive collaboration.
  • Summary
  • Transcript
  • Participants
  • Company
In this interview, filmed in Stockholm at NLSD 2013, Fintan Walton discusses with Anders Ekblom, Global Head Science and Technology Integration, how AstraZeneca are bringing external innovation into the organisation through pre-competitive collaboration.
In this interview, filmed in Stockholm at NLSD 2013, Fintan Walton discusses with Anders Ekblom, Global Head Science and Technology Integration, how AstraZeneca are bringing external innovation into the organisation through pre-competitive collaboration.
Anders Ekblom
AstraZeneca
AstraZeneca
AstraZeneca plc is a British-Swedish pharmaceutical company formed on 6 April 1999 by the remerger of Swedish Astra AB and British Zeneca Group plc. Zeneca had been part of Imperial Chemical Industries (ICI), as three divisions that were spun off from ICI on 1 June 1993. It is a public company and is listed on the London Stock Exchange, the New York Stock Exchange and the OMX exchange.